These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

612 related items for PubMed ID: 15329205

  • 21. The levels of serum fibrosis marks and morphometric quantitative measurement of hepatic fibrosis.
    Xie SB, Yao JL, Zheng SS, Yao CL, Zheng RQ.
    Hepatobiliary Pancreat Dis Int; 2002 May; 1(2):202-6. PubMed ID: 14607739
    [Abstract] [Full Text] [Related]

  • 22. [Investigation on indication of fuzheng huayu capsule against hepatic fibrosis and its non-invasive efficacy evaluation parameters: data analysis of liver biopsy of 50 patients with chronic hepatitis B before and after treatment].
    Hu YY, Liu P, Liu C.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2006 Jan; 26(1):18-22. PubMed ID: 16466166
    [Abstract] [Full Text] [Related]

  • 23. Replacement of hystological findings: serum hyaluronic acid for fibrosis, high-sensitive C-reactive protein for necroinflamation in chronic viral hepatitis.
    Yilmaz S, Bayan K, Tüzün Y, Dursun M, Kaplan A, Ozmen S, Canoruç F, Akkuş Z.
    Int J Clin Pract; 2007 Mar; 61(3):438-43. PubMed ID: 17313611
    [Abstract] [Full Text] [Related]

  • 24. [Biochemical markers of fibrosis in chronic hepatitis and liver cirrhosis of viral origin].
    Kozłowska J, Łoch T, Jabłońska J, Cianciara J.
    Przegl Epidemiol; 2001 Mar; 55(4):451-8. PubMed ID: 11921731
    [Abstract] [Full Text] [Related]

  • 25. The relationship between staging of hepatic fibrosis and the levels of serum biochemistry.
    Xu GG, Luo CY, Wu SM, Wang CL.
    Hepatobiliary Pancreat Dis Int; 2002 May; 1(2):246-8. PubMed ID: 14612277
    [Abstract] [Full Text] [Related]

  • 26. Danshao huaxian capsule in treatment of decompensated cirrhosis resulting from chronic hepatitis B.
    Cheng ML, Lu T, Yao YM, Geng XX.
    Hepatobiliary Pancreat Dis Int; 2006 Feb; 5(1):48-51. PubMed ID: 16481282
    [Abstract] [Full Text] [Related]

  • 27. Value of fibrosis markers for staging liver fibrosis in patients with precirrhotic alcoholic liver disease.
    Lieber CS, Weiss DG, Paronetto F, Veterans Affairs Cooperative Study 391 Group.
    Alcohol Clin Exp Res; 2008 Jun; 32(6):1031-9. PubMed ID: 18422837
    [Abstract] [Full Text] [Related]

  • 28. [Value of simultaneous determination of serum hyaluronic acid, collagen type IV and the laminin level in diagnosing liver fibrosis].
    Liang XH, Zheng H.
    Hunan Yi Ke Da Xue Xue Bao; 2002 Feb 28; 27(1):67-8. PubMed ID: 12575242
    [Abstract] [Full Text] [Related]

  • 29. [Diagnostic significance of type IV collagen and hyaluronic acid in the serum of patients with chronic hepatitis C for staging hepatic fibrosis].
    Iushchuk ND, Znoĭko OO, Safiullina NKh, Dudina KR, Kelli EI, Klimova EA, Kashirin VI, Braginskiĭ DM, Kushlinskiĭ NE, Liubimova NV, Vasilev AIu, Penkina TV, Danilin AG.
    Ter Arkh; 2005 Feb 28; 77(4):50-5. PubMed ID: 15938533
    [Abstract] [Full Text] [Related]

  • 30. [Clinical study on treatment of liver fibrosis in patients of hepatitis B by kangxian baogan decoction].
    Liang TJ, Zhang W, Zhang CQ.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2002 May 28; 22(5):332-4. PubMed ID: 12584827
    [Abstract] [Full Text] [Related]

  • 31. Serum hyaluronic acid during lamivudine treatment in chronic hepatitis B.
    Grzeszczuk A, Prokopowicz D.
    Rocz Akad Med Bialymst; 2004 May 28; 49():275-9. PubMed ID: 15631357
    [Abstract] [Full Text] [Related]

  • 32. [Clinical and pathological study on liver fibrosis in viral hepatitis].
    Xin S, Mao Y, Wang L, Li Y, Li L, Yu H, Zhao M, Zhang S, Wang S, Wang X, Chen L, Zhou X, Zhou Y, Zou Z, Tang S, Huangpu Y, Zhang L.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Sep 28; 11(3):240-3. PubMed ID: 15617338
    [Abstract] [Full Text] [Related]

  • 33. Serum markers of liver fibrosis and histologic severity of fibrosis in resected liver.
    Tsukamoto T, Yamamoto T, Ikebe T, Takemura S, Shuto T, Kubo S, Hirohashi K, Kinoshita H.
    Hepatogastroenterology; 2004 Sep 28; 51(57):777-80. PubMed ID: 15143915
    [Abstract] [Full Text] [Related]

  • 34. [The detection and clinical significance of hepatic fibrosis index].
    Xu CH, Meng DM, Lv SL, Kang P.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2010 Feb 28; 24(1):50-2. PubMed ID: 20848851
    [Abstract] [Full Text] [Related]

  • 35. A double-blind placebo-controlled study of emtricitabine in chronic hepatitis B.
    Lim SG, Ng TM, Kung N, Krastev Z, Volfova M, Husa P, Lee SS, Chan S, Shiffman ML, Washington MK, Rigney A, Anderson J, Mondou E, Snow A, Sorbel J, Guan R, Rousseau F, Emtricitabine FTCB-301 Study Group.
    Arch Intern Med; 2006 Jan 09; 166(1):49-56. PubMed ID: 16401810
    [Abstract] [Full Text] [Related]

  • 36. Effects of indomethacin on viral replication markers in asymptomatic carriers of hepatitis B: a randomized, placebo-controlled trial.
    Bahrami H, Daryani NE, Haghpanah B, Moayyeri A, Moghadam KF, Mirmomen S, Kamangar F.
    Am J Gastroenterol; 2005 Apr 09; 100(4):856-61. PubMed ID: 15784032
    [Abstract] [Full Text] [Related]

  • 37. [Relationships between liver function test, serum HBeAg or HBV DNA level and liver pathological changes in patients with chronic hepatitis B].
    Xu QH, Shu X, Chen LB, Huang HH, Zhang K, Li G.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Dec 09; 22(6):422-4. PubMed ID: 19544633
    [Abstract] [Full Text] [Related]

  • 38. Long-term follow-up of interferon-treated chronic hepatitis C and serum hepatic fibrosis markers.
    Ueno T, Ide T, Hashimoto O, Uchimura Y, Torimura T, Kumashiro R, Inuzuka S, Sata M.
    Hepatogastroenterology; 2001 Dec 09; 48(40):1124-8. PubMed ID: 11490815
    [Abstract] [Full Text] [Related]

  • 39. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ, Wilens TE, Biederman J, Weisler RH, Read SC, Pratt R.
    Clin Ther; 2006 Feb 09; 28(2):266-79. PubMed ID: 16678648
    [Abstract] [Full Text] [Related]

  • 40. [Indigenous and imported low molecular weight heparin in the treatment of chronic hepatitis B and cirrhosis with hepatitis B virus: a prospective randomized controlled clinical study].
    Huang JS, Luo X, Yu JX, Liu W, Chen XW, Xie L, Zhu XY, Chen GY.
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Jul 09; 19(7):408-11. PubMed ID: 17631708
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 31.